Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study
OPEN PLoS medicine | 9 Sep 2020
LC Lund, KB Kristensen, M Reilev, S Christensen, RW Thomsen, CF Christiansen, H Støvring, NB Johansen, NC Brun, J Hallas and A Pottegård
Concerns over the safety of non-steroidal anti-inflammatory drug (NSAID) use during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have been raised. We studied whether use of NSAIDs was associated with adverse outcomes and mortality during SARS-CoV-2 infection.
* Data courtesy of Altmetric.com